Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
0.5612
-0.0145 (-2.52%)
Jul 30, 2026, 1:35 PM EDT - Market open
Gelteq Employees
As of June 30, 2025, Gelteq had 8 total employees, including 7 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$39,338
Profits / Employee
-$590,582
Market Cap
6.28M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 8 | 0 | - | 7 | 1 |
| Jun 30, 2024 | 8 | 0 | - | 7 | 1 |
| Jun 30, 2023 | 8 | 5 | 166.67% | 7 | 1 |
| Jun 30, 2021 | 3 | - | - | 3 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Biofrontera | 94 |
| Aytu BioPharma | 83 |
| Sunshine Biopharma | 50 |
| cbdMD | 42 |
| InMed Pharmaceuticals | 13 |
| RedHill Biopharma | 13 |
| Sonoma Pharmaceuticals | 10 |
| PRF Technologies | 7 |
GELS News
- 6 weeks ago - Gelteq Transcript: Planet MicroCap Las Vegas 2026 - Transcripts
- 6 weeks ago - Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs - GlobeNewsWire
- 6 weeks ago - Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications - GlobeNewsWire
- 2 months ago - Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion - GlobeNewsWire
- 2 months ago - Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway - GlobeNewsWire
- 2 months ago - Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA - Accesswire
- 2 months ago - Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth - GlobeNewsWire
- 4 months ago - Healthy Extracts Reports 2025 Net Revenue Up 45% to Record $4.5 Million - Accesswire